ARQT - Company ID 0001787306
The table below shows Arcutis Biotherapeutics, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $42.91M | $71.33M | $88.39M | $53.64M | $96.45M | $65.08M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $146.23M | $73.07M | $25.81M | $8.46M | - | - |
| Inventory | $22.63M | $14.53M | $13.13M | $7.51M | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $411.23M |
| $335.82M |
| $330.43M |
| $437.41M |
| $402.77M |
| $292.83M |
| Property, plant & equipment | $1.04M | $1.04M | $1.54M | $1.88M | $2.26M | $2.02M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $432.97M | $348.89M | $341.37M | $449.27M | $408.15M | $298.27M |
| Accounts payable | $12.53M | $14.22M | $11.99M | $8.83M | $7.35M | $7.14M |
| Total current liabilities | $129.84M | $81.01M | $46.67M | $37.81M | $33.33M | $22.60M |
| Long-term debt | $107.96M | $107.20M | $201.80M | $197.77M | $72.35M | - |
| Total liabilities | $243.49M | $191.35M | $252.70M | $239.69M | $110.47M | $27.65M |
| Retained earnings | -$1.14B | -$1.12B | -$981.90M | -$719.76M | -$408.31M | -$201.95M |
| Total equity | $189.48M | $157.54M | $88.67M | $209.58M | $297.68M | $270.62M |